港股詳情

本页面由TTMF Limited提供服务

英派藥業-B待上市

成交量：- -

成交額：- -

市值：- -

市盈率：- -

高：- -

開：- -

低：- -

收：- -

52周最高：- -

52周最低：- -

股本：2.34億

香港流通股本：2.34億

量比：- -

換手率：- -

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

市銷率: - -

1

开始申购

05/05

2

申購截止

05/08 10:15

3

公布中签

05/11

4

暗盘

05/12 16:15 - 18:30

5

挂牌上市

05/13

總覽公司新聞資訊公告

价格范围

19.75 ~ 21.75 HKD

发行价

- -

发行量

4,197.70萬

预计市值

54.54億 ~ 60.07億 HKD

最低申购数量

200

承销商

高盛(亞洲)有限責任公司

查看招股说明书

新聞資訊

新股孖展統計 | 5月6日

智通财经网

「港股合成致死腫瘤藥第一股」英派藥業啓動招股，明星基石加持，擬5月13日上市

即將亮相：港股合成致死腫瘤藥第一股英派藥業

医药投资部落

港股18A再迎明星biotech，英派藥業招股開始，合成致死稀缺標的獲豪華基石認購

信阳新闻网

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/07630"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"07630","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07630\",,,,,undefined,":{"symbol":"07630","market":"HK","secType":"STK","nameCN":"英派藥業-B","latestPrice":0,"timestamp":1778054400000,"preClose":0,"halted":7,"volume":0,"delay":0,"floatShares":234000000,"shares":234000000,"eps":0,"marketStatus":"待上市","change":0,"latestTime":"05-06 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1778635800000},"marketStatusCode":8,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1778031000000,1778040000000],[1778043600000,1778054400000]],"volumeRatio":0,"ipoDetail":{"name":"英派药业－Ｂ","exchange":"SEHK","listingDate":"2026-05-13","sharesOutstanding":276165130,"sharesFloat":276165130,"offerAmount":41977000,"priceRange":"19.750 - 21.750","market":"HK","openProspectusDate":"2026-05-05","openProspectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0505/2026050500024_c.pdf","purchaseBeginDate":"2026-05-05","purchaseEndDate":"2026-05-08","winningDate":"2026-05-12","currency":"HKD","minPurchaseQuantity":200,"peRate":-17.52,"use":"1、约51%或398.37百万港元将用于为核心产品塞纳帕利正在进行及计划中的临床开发、监管批准以及商业化提供资金；\n2、约31%或242.15百万港元将用于为关键产品IMP1734及IMP9064正在进行的临床开发提供资金；\n3、约8%或62.49百万港元将用于为其他管线资产、IMP1707、IMP7068、IMP22、IMP25、IMP08、IMP13及IMP10的研发活动提供资金；\n4、约8%或62.49百万港元将用于为研发平台的开发及扩大药物管线提供资金；\n5、约2%或15.62百万港元将用于营运资金及其他一般公司用途。","industryId":"204005","industryName":"医疗保健","business":"公司是一家处于商业化阶段的创新驱动型生物技术公司，致力于在全球范围内推进基于合成致死(synthetic lethality)机制的精准抗癌疗法，打造创新疗法，以满足癌症患者未被满足的医疗需求。公司自主研发的核心产品塞纳帕利已在中国获批上市，作为卵巢癌一线维持疗法，适用于全人群（无论突变状态），并展现出令人信服的临床特征。通过整合小分子药物与新兴疗法（包括新型抗体偶联药物和蛋白降解剂）的自主研发平台，公司持续推动创新突破。","subscribed":86.91,"marketCap":5454000000,"minimumCapital":4393.88,"overAllotment":true,"lotSize":200,"issueOpenRate":0.1,"subscribeGear":"200,400,600,800,1000,1200,1400,1600,1800,2000,3000,4000,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,200000,300000,400000,500000,600000,700000,800000,900000,1000000,1250000,1500000,1750000,2098800","issueRatio":0.1,"offeringMechanism":"B"},"greyMarketDetail":{"greyDate":"2026-05-12","greyDateTimestamp":1778515200000,"greyOpeningTime":1778573700000,"greyClosingTime":1778581800000,"showGreyQuote":false,"openProspectusDate":"2026-05-05","listingDate":"2026-05-13"},"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07630\",,,,,undefined,":{"symbol":"07630","floatShares":234000000,"roa":"--","roe":"--","lyrEps":0,"shares":234000000,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hktrade.skytigris.com/ipos/general/07630\",,undefined,":{"id":9966,"type":"COMMON","ipoName":"07630-IPO","symbol":"07630","companyName":"英派藥業-B","market":"HK","currency":"HKD","status":"OPEN","underwriter":"高盛(亞洲)有限責任公司","lotSize":200,"minQty":200,"expectedOfferingSize":41977000,"openingDate":1777944600000,"closingDate":1778206500000,"commonClosingDate":1778206500000,"allotmentDate":1778428800000,"listDate":1778601600000,"marginable":true,"marginRate":10,"latestPrice":21.75,"minPrice":19.75,"maxPrice":21.75,"prospectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0505/2026050500024_c.pdf","allowedQuantities":[200,400,600,800,1000,1200,1400,1600,1800,2000,3000,4000,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,200000,300000,400000,500000,600000,700000,800000,900000,1000000,1250000,1500000,1750000,2098800],"interestRate":0,"recommend":false,"isHint":false,"interestStartDate":1778169600000,"interestEndDate":1778342400000,"delayAllocate":false,"isSupportGreyMarket":true,"greyMarketTradeDate":1778573700000,"transactionRate":0.010085,"gstFeeRate":0,"rank":0,"subscribed":false,"signed":false,"financingInfos":[{"ipoName":"07630-IPO","ipoId":9966,"financingId":59526,"type":1,"availableFundLimit":4393.86,"piAvailableAmountLimit":0,"piMaxAvailableAmountLimit":-1,"piMinSubscribeAmount":0,"piMaxSubscribeAmount":-1,"minSubscribeLimit":43938.6,"maxSubscribeLimit":-1,"marginRate":10,"interestRate":0,"openTime":1777944600000,"closeTime":1778206500000,"isAtValidTime":true,"subscriptionMethod":"FINANCING","processFee":0,"supportPI":false,"applyFundLimit":4393.86,"threshold":50000000000,"isAvailable":false},{"ipoName":"07630-IPO","ipoId":9966,"financingId":59519,"type":4,"availableFundLimit":4393.86,"piAvailableAmountLimit":0,"piMaxAvailableAmountLimit":-1,"piMinSubscribeAmount":0,"piMaxSubscribeAmount":-1,"minSubscribeLimit":0,"maxSubscribeLimit":-1,"marginRate":100,"interestRate":0,"openTime":1777944600000,"closeTime":1778206500000,"isAtValidTime":true,"subscriptionMethod":"CASH","processFee":0,"supportPI":false,"applyFundLimit":4393.86,"threshold":50000000000,"isAvailable":false}],"financingNotifyEnabled":false,"financingNotifySubscribed":false,"subscriptionMethods":[{"method":"FINANCING","closeTime":1778206500000,"available":false,"messageCode":"AVAILABLE_FUND_LIMIT","minAvailableFundLimit":4393.86},{"method":"CASH","closeTime":1778206500000,"available":false,"messageCode":"AVAILABLE_FUND_LIMIT","minAvailableFundLimit":4393.86}],"latestClosingDate":1778206500000,"subscribedFinanceRatio":86.91,"subscribedRatio":86.91,"forecastRatio":118.2,"raiseMoney":91300000,"totalMargin":7935490000,"quoteInfoUpdatedAt":1778098049770,"prospectusUpdatedAt":1778048316000,"forecastMarketValue":5730426447.5,"minForecastMarketValue":5454261317.5,"maxForecastMarketValue":6006591577.5,"sharesOutstanding":276165130,"business":"公司是一家處於商業化階段的創新驅動型生物技術公司，致力於在全球範圍內推進基於合成致死(synthetic lethality)機制的精準抗癌療法，打造創新療法，以滿足癌症患者未被滿足的醫療需求。公司自主研發的核心產品塞納帕利已在中國獲批上市，作為卵巢癌一線維持療法，適用於全人群（無論突變狀態），並展現出令人信服的臨床特徵。通過整合小分子藥物與新興療法（包括新型抗體偶聯藥物和蛋白降解劑）的自主研發平台，公司持續推動創新突破。","greyOpeningTime":1778573700000,"greyClosingTime":1778581800000,"tradable":true,"showClawback":true,"clawbackType":"機制B","clawbackRate":10},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"07630\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633918418","title":"新股孖展統計 | 5月6日","url":"https://stock-news.laohu8.com/highlight/detail?id=2633918418","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633918418?lang=zh_tw&edition=fundamental","pubTime":"2026-05-06 18:27","pubTimestamp":1778063248,"startTime":"0","endTime":"0","summary":"英派药业-B(07630)、剂泰科技-P(07666)正在招股中。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260506/20260506182748_22433.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260506/20260506182748_22433.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438629.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["07666","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114924651","title":"「港股合成致死腫瘤藥第一股」英派藥業啓動招股，明星基石加持，擬5月13日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1114924651","media":"同壁财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114924651?lang=zh_tw&edition=fundamental","pubTime":"2026-05-06 15:27","pubTimestamp":1778052443,"startTime":"0","endTime":"0","summary":"据消息，南京英派药业股份有限公司于2026年5月5日至8日开启招股， 公司拟全球发售约4198万股H股，每股发售价最高至21.75港元，募资规模最高超9亿港元。公司预计将于2026年5月13日在港股主板上市。其中，IMP32是全球首个、且目前唯一靶向CEACAM5的TOP1i+ATRi双载荷ADC，凭借明确的合成致死协同效应，已成为全球巨头战略布局的核心方向。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tongbicapital.com/news?id=1116351&feClassCode=hsag","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1668077363049","symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123297572","title":"即將亮相：港股合成致死腫瘤藥第一股英派藥業","url":"https://stock-news.laohu8.com/highlight/detail?id=1123297572","media":"医药投资部落","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123297572?lang=zh_tw&edition=fundamental","pubTime":"2026-05-06 15:25","pubTimestamp":1778052358,"startTime":"0","endTime":"0","summary":"汇聚了中国创新药行业核心资产的港股18A板块，即将迎来又一家创新药细分赛道的龙头企业：有着“合成致死肿瘤药第一股”之称的英派药业，已在5月5日开启港股招股流程，预计5月13日于香港联交所主板挂牌上市。新技术赛道扩展市场往往习惯将英派药业定位为一家深度绑定合成致死赛道的小分子药物公司，这一判断并不全面。这意味着，英派药业的技术半径正从合成致死小分子药物赛道，延伸到围绕肿瘤治疗的多种前沿技术路线。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://mp.weixin.qq.com/s/IRYuOSKv3y13KkTaFyQC4A?from=groupmessage&scene=1&subscene=10000&sessionid=1778048506&clicktime=1778050535&enterid=1778050535&ascene=1&fasttmpl_type=0&fasttmpl_fullversion=8237539-zh_CN-zip&fasttmpl_flag=0&realreporttime=1778050535337","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1629166856219","symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633092917","title":"港股18A再迎明星biotech，英派藥業招股開始，合成致死稀缺標的獲豪華基石認購","url":"https://stock-news.laohu8.com/highlight/detail?id=2633092917","media":"信阳新闻网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633092917?lang=zh_tw&edition=fundamental","pubTime":"2026-05-05 19:43","pubTimestamp":1777981409,"startTime":"0","endTime":"0","summary":"2026年5月5日，南京英派药业股份有限公司（简称“英派药业”，股票代码:07630.HK）开启招股，拟全球发售约4198万股H股(视乎发售量调整权及超额配股权行使与否而定)，其中中国香港发售股份约420万股，国际发售股份约3778万股；2026年5月5日至5月8日招股，每股发售价格最高至21.75港元，每手买卖单位为200股，募集资金规模最高超9亿港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.p5w.net/roll/finance/202605/t20260505_6469559.htm","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1778052843920","symbols":["07630","BK4087","BK4588","VXUS","BK4585","IPOS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}